Meru Biotechnologies

Meru Biotechnologies was founded with the core mission of revolutionizing analytical platforms through label-free analysis. The company's vision is to simplify and enhance the accuracy of biochemical measurements. Their flagship product, Free Solution Analysis (FSA), leverages Compensated Interferometry technology, utilizing a single laser to simultaneously measure experimental and reference samples within a microfluidic setup. This innovative approach aims to provide precise, straightforward analytical solutions for various scientific and medical applications.

Notable figures associated with Meru Biotechnologies include leading experts in biotechnology and analytical chemistry. The company has attracted significant interest from investors focused on cutting-edge scientific advancements. Key achievements include the successful development and deployment of their FSA platform, which has garnered attention for its potential to streamline and improve the accuracy of biochemical analyses. Overall, Meru Biotechnologies is making a substantial impact in the field of label-free analysis, promising to enhance research capabilities across multiple disciplines.